About Royal National Hospital for Rheumatic Diseases
The Royal National Hospital for Rheumatic Diseases is a small, specialist NHS hospital on the Royal United Hospital site in the northwestern outskirts of Bath, England.
Clinical Trials at Royal National Hospital for Rheumatic Diseases
During the past decade, Royal National Hospital for Rheumatic Diseases conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Royal National Hospital for Rheumatic Diseases" #1 sponsor was "MediQuest Therapeutics" with 2 trials, followed by "Amgen" with 1 trials
sponsored, "Cephalon, Inc." with 1 trials sponsored, "EMD Serono" with 1 trials sponsored and "Janssen Pharmaceutica N.V., Belgium"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at Royal National Hospital for Rheumatic Diseases
According to Clinical.Site data, the most researched conditions in "Royal National Hospital for Rheumatic Diseases" are
"Ankylosing Spondyloarthritis" (1 trials), "Arthritis, Psoriatic" (1 trials), "Autoimmune Diseases" (1 trials), "Fingernail Psoriasis" (1 trials) and "Lupus Erythematosus, Systemic" (1 trials). Many other conditions were trialed in "Royal National Hospital for Rheumatic Diseases" in a lesser frequency.
Clinical Trials Intervention Types at Royal National Hospital for Rheumatic Diseases
Most popular intervention types in "Royal National Hospital for Rheumatic Diseases" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Apremilast tablet 20 mg" (1 trials), "Apremilast tablet 30 mg BID" (1 trials), "Atacicept 150 mg" (1 trials) and "Atacicept 75 milligram (mg)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Royal National Hospital for Rheumatic Diseases
The vast majority of trials in "Royal National Hospital for Rheumatic Diseases" are
6 trials for "All" genders.
Clinical Trials Status at Royal National Hospital for Rheumatic Diseases
Currently, there are NaN active trials in "Royal National Hospital for Rheumatic Diseases".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Royal National Hospital for Rheumatic Diseases,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Royal National Hospital for Rheumatic Diseases, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".